Login / Signup

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.

Judith S CurrierCarlee B MoserJoseph J EronKara W ChewDavey M SmithArzhang Cyrus JavanDavid Alain WohlEric S DaarMichael D Hughesnull null
Published in: The Journal of infectious diseases (2023)
Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.
Keyphrases
  • clinical trial
  • coronavirus disease
  • sars cov
  • phase ii
  • phase iii
  • study protocol
  • small molecule
  • high throughput
  • randomized controlled trial
  • open label